The company recently added a 15,000-square-foot lab at its Bioanalytical Center of Excellence that increased its early-phase large molecule capabilities, the report said. It is expecting to hire 55 more employees in the next year, a more than 50 percent increase over its current team of 90.
With the new lab, Worldwide intends to grow its pharmacokinetics, antidrug antibodies and biomarkers sample analysis scale from about 70,000 to about 200,000 by 2024, the report said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
